NCT06374420Completed
Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome
Source: ClinicalTrials.gov · Last updated 19 Apr 2024
Brief summary (registry, in English)
The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 16 Apr 2024
- Start date
- 1 Sept 2021
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- Mansoura University
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06374420
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Sept 2021 to the primary completion date, 1 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hospitalized or requiring intensive care unit. Known patients with chronic lung diseases Uncontrolled comorbidities
Who the study is looking for
- Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mansoura University Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.